Clinical Preventive Medicine
Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type
The purpose of this study was to test the hypothesis that patients with Medicaid insurance or Medicaid-like coverage would have longer times to follow-up and be less likely to complete colonoscopy compared with patients with commercial insurance within the same healthcare systems.Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation
The U.S. Preventive Services Task Force recommends that primary care providers screen unaffected women with a family history of BRCA mutation-associated cancers, but without a personal history of BRCA-related cancer, for referral to genetic counseling and potential genetic testing.A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care
Personal risk for multiple conditions should be assessed in primary care. This study evaluated whether collection of risk factors to generate electronic health record (EHR)-linked health risk appraisal (HRA) for coronary heart disease, diabetes, breast cancer, and colorectal cancer was associated with improved patient–provider communication, risk assessment, and plans for breast cancer screening.Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly
Expert recommendations differ for colorectal cancer screening in the elderly. Recent studies suggest that healthy adults aged >75 years may benefit from screening. This study examined screening use and follow-up, and how they varied by health status within age strata, among a large cohort of elderly individuals in community settings.Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity
Timely follow-up of abnormal tests is critical to the effectiveness of cancer screening, but may vary by screening test, healthcare system, and sociodemographic group.
